Personal Hand Hygiene System for Surgical Site Infection
(ESKAPE Trial)
Trial Summary
What is the purpose of this trial?
This trial is testing a new hand cleaning and germ tracking system to reduce infections in adult surgery patients. The goal is to ensure doctors have cleaner hands and to monitor harmful bacteria in the operating room.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment SafeHaven Automated Hand Hygiene Device for preventing surgical site infections?
Research shows that automated hand hygiene systems can improve hand hygiene practices, which are crucial for preventing infections in healthcare settings. These systems, by monitoring and providing feedback, have been associated with better hand hygiene compliance and reduced healthcare-associated infections.12345
How is the SafeHaven Personal Hand Hygiene System different from other treatments for surgical site infections?
The SafeHaven Personal Hand Hygiene System is unique because it uses an automated and electronic system to monitor and improve hand hygiene compliance, which is crucial for preventing surgical site infections. Unlike traditional methods, it involves sensors and badges to track hand hygiene events, providing real-time feedback to healthcare workers.12367
Research Team
Brandon M Togioka, MD
Principal Investigator
Oregon Health and Science University
Eligibility Criteria
This trial is for adult anesthesia providers and patients undergoing certain surgeries at the research center. Providers must be involved in adult surgeries, while patients need to be adults having specific types of surgery like orthopedics or cardiothoracic. Excluded are those with open hand sores, prisoners, pregnant women, anyone unable to consent, known infections at surgery time, refusal to consent, skin infections or allergies to hand hygiene solutions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Perioperative
Use of SafeHaven hand hygiene system or standard care hand hygiene during surgery; microbial cultures collected at case start and end
Follow-up
Participants are monitored for ESKAPE pathogen transmission events using OR PathTrac software
Treatment Details
Interventions
- SafeHaven Automated Hand Hygiene Device (Other)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Oregon Health and Science University
Lead Sponsor
John Hunter
Oregon Health and Science University
Chief Medical Officer since 2024
MD, specific details unavailable
Ann Madden Rice
Oregon Health and Science University
Chief Executive Officer
FACHE certification, extensive leadership experience in academic health centers
Georgia-Pacific Consumer Products LP
Collaborator
University of Iowa
Collaborator
Dr. Afable
University of Iowa
Chief Medical Officer since 2005
MD from Loyola Stritch School of Medicine, MPH from the University of Illinois
Joel Harris
University of Iowa
Chief Executive Officer since 2023
B.A. in Economics from the University of Iowa, Post-baccalaureate Certificate in Narrative Communications from Northwestern University
RDB Informatics
Collaborator